{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T21:39:55Z","timestamp":1772660395121,"version":"3.50.1"},"reference-count":22,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.3892\/mco.2016.1029","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T11:15:11Z","timestamp":1474456511000},"page":"579-582","source":"Crossref","is-referenced-by-count":8,"title":["Favorable control of advanced colon adenocarcinoma with severe bone marrow metastasis: A case report"],"prefix":"10.3892","volume":"5","author":[{"given":"Fumiyasu","family":"Hanamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Kuwayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisanobu","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ariyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taito","family":"Esaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eishi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,9,21]]},"reference":[{"key":"key20180107150258_b1-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/1097-0142(19941101)74:9<2403::AID-CNCR2820740904>3.0.CO;2-F","article-title":"Bone marrow metastases. A review","volume":"74","author":"Papac","year":"1994","journal-title":"Cancer"},{"key":"key20180107150258_b2-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.breast.2005.08.023","article-title":"Prognostic and predictive factors revisited","volume":"14","author":"Hayes","year":"2005","journal-title":"Breast"},{"key":"key20180107150258_b3-mco-0-0-1029","first-page":"5587","article-title":"Metastatic bone cancer as a recurrence of early gastric cancer-characteristics and possible mechanisms","volume":"11","author":"Kobayashi","year":"2005","journal-title":"World J Gastroenterol"},{"key":"key20180107150258_b4-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1200\/JCO.2003.02.009","article-title":"Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer","volume":"21","author":"Wiedswang","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180107150258_b5-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1242458","article-title":"Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors","volume":"22","author":"Haggar","year":"2009","journal-title":"Clin Colon Rectal Surg"},{"key":"key20180107150258_b6-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.clcc.2014.05.002","article-title":"An aggressive presentation of colorectal cancer with an atypical lymphoproliferative pattern of metastatic disease: A case report and review of the literature","volume":"13","author":"Shah","year":"2014","journal-title":"Clin Colorectal Cancer"},{"key":"key20180107150258_b7-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/jjco\/hyh082","article-title":"A case of bone marrow necrosis with thrombotic thrombocttopenic purpura as a manifestation of occult colon cancer","volume":"34","author":"Lee","year":"2004","journal-title":"Jpn J Clin Oncol"},{"key":"key20180107150258_b8-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00508-007-0774-7","article-title":"Massive infiltration of bone marrow in colon carcinoma after treatment with activated protein C","volume":"119","author":"Pleyer","year":"2007","journal-title":"Wiener Klinische Wochenschrift"},{"key":"key20180107150258_b9-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1200\/JCO.2008.21.3140","article-title":"Bone marrow necrosis caused by metastatic colon cancer","volume":"27","author":"Wang","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107150258_b10-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1182\/blood-2012-03-417386","article-title":"Metastatic adenocarcinoma involving the bone marrow","volume":"120","author":"Song","year":"2012","journal-title":"Blood"},{"key":"key20180107150258_b11-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ajh.10377","article-title":"Comparison of diagnostic criteria For Disseminated Intravascular Coaglation (DIC): Diagnostic criteria of the International Society of Thrombosis and Hemostasis (ISTH) and of the Japanese Ministry of Health and Welfare for Overt DIC","volume":"74","author":"Wada","year":"2003","journal-title":"Am J Hematol"},{"key":"key20180107150258_b12-mco-0-0-1029","year":"2010","journal-title":"Common Terminology Criteria for Adverse Events v4.0. NIH Publication: Number 10-5410"},{"key":"key20180107150258_b13-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM200002243420801","article-title":"Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer","volume":"342","author":"Braun","year":"2000","journal-title":"N Engl J Med"},{"key":"key20180107150258_b14-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"12249","DOI":"10.3748\/wjg.v21.i43.12249","article-title":"Recent aspects for disseminated carcinomatosis of the bone marrow associated with gastric cancer: What has been done for the past, and what will be needed in future?","volume":"21","author":"Iguchi","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20180107150258_b15-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/PAS.0b013e31824430d7","article-title":"BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: An aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features","volume":"36","author":"Pai","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"key20180107150258_b16-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3109\/0284186X.2014.895036","article-title":"The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis","volume":"53","author":"Therkildsen","year":"2014","journal-title":"Acta Oncol"},{"key":"key20180107150258_b17-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/0008-5472.CAN-08-2466","article-title":"PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies","volume":"69","author":"Sartore-Bianchi","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107150258_b18-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ncb0804-699","article-title":"Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds","volume":"6","author":"Coulombe","year":"2004","journal-title":"Nat Cell Biol"},{"key":"key20180107150258_b19-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.prp.2010.12.005","article-title":"Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas","volume":"207","author":"Bayrak","year":"2011","journal-title":"Pathol Res Pract"},{"key":"key20180107150258_b20-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.5858\/2007-131-1561-POIMHD","article-title":"Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma","volume":"131","author":"Park","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"key20180107150258_b21-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5301\/JBM.2008.649","article-title":"Prognostic value of cytokeratin 19 fragment (CYFRA 21-1) and cytokeratin-positive cells in bone marrow samples of breast cancer patients","volume":"19","author":"Pierga","year":"2004","journal-title":"Int J Biol Markers"},{"key":"key20180107150258_b22-mco-0-0-1029","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1506597","article-title":"CDX2 as a prognostic biomarker in stage II and stage III colon cancer","volume":"374","author":"Dalerba","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2016.1029\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T22:42:13Z","timestamp":1657320133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2016.1029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,21]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,9,21]]},"published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.3892\/mco.2016.1029"],"URL":"https:\/\/doi.org\/10.3892\/mco.2016.1029","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,21]]}}}